Search results
Results from the WOW.Com Content Network
Treatment regimens outside a clinical trial should include at least two agents. Every regimen should contain either azithromycin or clarithromycin; many experts prefer ethambutol as a second drug. Many clinicians have added one or more of the following as second, third, or fourth agents: clofazimine, rifabutin, rifampin, ciprofloxacin, and in ...
Rates of Mycoplasma pneumonia in all global community-acquired pneumonia (CAP) cases range from 10-15%. [13] [14] The rate of Mycoplasma pneumonia in adults with CAP is estimated to be 15%, and the rate of in children with CAP has been reported at 27.4%. [3] The rates of M. pneumoniae among hospitalized CAP cases are 35% in adults [14] and 24% ...
Doctors treat mycoplasma pneumonia, like other forms of pneumonia, with antibiotics; however, only certain forms, such as azithromycin (also known as a Z-Pak), are effective against it.
Mycobacteria are a family of small, rod-shaped bacilli that can be classified into three main groups for diagnosis and treatment: Mycobacterium tuberculosis complex, which can cause tuberculosis: M. tuberculosis, M. bovis, M. africanum, M. microti and M. canettii; M. leprae and M. lepromatosis, which cause Hansen's disease, also called leprosy
Tetracyclines, macrolides, ketolides, quinolones are used to treat mycoplasma infections. In addition to the penicillins, mycoplasmas are resistant to rifampicin . Mycoplasmas may be difficult to eradicate from human or animal hosts or from cell cultures by antibiotic treatment because of resistance to the antibiotic, or because it does not ...
Mycoplasma pneumoniae is a species of very small-cell bacteria that lack a cell wall, in the class Mollicutes. M. pneumoniae is a human pathogen that causes the disease Mycoplasma pneumonia , a form of atypical bacterial pneumonia related to cold agglutinin disease .
Mycoplasma gallisepticum (MG) is a bacterium in the class Mollicutes and the family Mycoplasmataceae. It causes chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys, chickens, game birds, pigeons, and passerine birds of all ages.
Mycoplasma hominis is an opportunistic human mycoplasma species residing in the lower urogenital tract. [10] It is a common human urogenital Mycoplasma species that lacks a cell wall. Due to the absence of the cell wall, M. hominis is innately resistant to β-lactams and to all antibiotics which target the cell wall. [ 11 ]